dengyuepharma

dengyuepharma Ajouter une nouvelle offre d'emploi Fitness
2026-01-13 08:34:05 - Traduire

Tenofovir Amibufenamide, a rising star in chronic hepatitis B treatment: How to achieve significant therapeutic effects with low dosage?
2026-01-13 Written by DengyueMed Tenofovir Amibufenamide (Hengmu®) is a next-generation tenofovir prodrug independently developed in China for the treatment of chronic hepatitis B (CHB). Designed with optimized molecular structure and enhanced liver targeting, Tenofovir Amibufenamide delivers potent antiviral efficacy at a significantly lower dose, while offering a favorable long-term...

0 Commentaires 0 Parts 4KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
dengyuepharma Ajouter une nouvelle offre d'emploi Fitness
2026-01-07 08:48:23 - Traduire

Trastuzumab Botidotin: Ushering HER2-Targeted Therapy into a New Era of Dual-Epitope Synergy
As precision oncology continues to advance, HER2 (human epidermal growth factor receptor 2) has become one of the most mature and clinically valuable therapeutic targets across multiple solid tumors. With an improved understanding of tumor heterogeneity and mechanisms of drug resistance, the limitations of single-target, single-mechanism treatment strategies have become increasingly evident....

0 Commentaires 0 Parts 991 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
dengyuepharma Mise à jour de la photo de profil
2026-01-06 09:24:21 - Traduire

0 Commentaires 0 Parts 699 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!

Plus de lecture